Cargando…
Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
Objectives: To evaluate the total and outpatient economic burden of aspergillosis, and to describe the outpatient antifungal treatment of aspergillosis within a large, commercially-insured population in the United States. Methods: Adults with at least one medical claim with an aspergillosis diagnosi...
Autores principales: | Durden, Emily, McMorrow, Donna, Juneau, Paul, Fowler, Robert, Chaudhari, Paresh, Horn, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia Data Analytics, LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471362/ https://www.ncbi.nlm.nih.gov/pubmed/37662021 http://dx.doi.org/10.36469/9862 |
Ejemplares similares
-
COVID-19-Associated Pulmonary Aspergillosis Complicated by Severe Coronavirus Disease: Is Detection of Aspergillus in Airway Specimens Before Disease Onset an Indicator of Antifungal Prophylaxis?
por: Kitayama, Takaaki, et al.
Publicado: (2023) -
Allergic Bronchopulmonary Aspergillosis Mimicking Lung Cancer: A Case Report
por: Torre-De León, Alejandro J, et al.
Publicado: (2023) -
Pulmonary Aspergillosis Complicated by Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review
por: Ali, Rafal S, et al.
Publicado: (2022) -
Should Preventive Antifungal Treatment Be Given to Patients With Abdominal Contamination in the Intensive Care Unit?
por: Demir Onder, Kubra, et al.
Publicado: (2023) -
E-cigarette or Vaping Product Use-Associated Lung Injury Complicated by Pulmonary Aspergillosis
por: Kupelian, Chloe, et al.
Publicado: (2021)